
Sai Life Sciences Ltd. share price
NSE: SAILIFE · Healthcare
₹1,800.20 -6.67%
Closing price data, updated 17 Nov 2026. 52-week range: -7.9% from high, +129.7% above low.
Price₹1,800.20
Market cap₹38,240 Cr
P/E101.6
P/B14.23
ROE15.1%
ROCE18.1%
Debt / equity0.12
Dividend yield0.00%
EPS₹17.71
Book value₹126.55
Operating margin21.9%
Dipscan score51 / 100
Share: WhatsAppX / TwitterTelegram
Sai Life Sciences Ltd. shareholding pattern
As of Sep 2026: Promoters 34.50%, FIIs 19.91%, DIIs 32.32%, Government 0.00%, Public 7.21%, Others 6.05%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 34.50% | 34.53% | 34.61% | 34.70% | 34.94% | 35.15% |
| FIIs | 19.91% | 19.65% | 21.17% | 21.40% | 22.50% | 14.58% |
| DIIs | 32.32% | 32.71% | 31.54% | 31.41% | 29.91% | 21.64% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 7.21% | 6.78% | 6.13% | 5.95% | 7.91% | 6.56% |
| Others | 6.05% | 6.33% | 6.56% | 6.54% | 4.74% | 22.07% |
| No. of Shareholders | 143,124 | 125,096 | 117,527 | 114,820 | 119,705 | 126,380 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| -6.67% | +0.85% | +25.70% | +24.05% | +61.82% | +100.64% |
Growth
| Sales growth, 3 years | +21.3% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +226.9% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | – |
| Latest quarter profit vs last year | – |
Strengths and weaknesses
Strengths
- Company has delivered good profit growth of 42.2% CAGR over last 5 years
Weaknesses
- Stock is trading at 14.2 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.7% over last 3 years.
- Working capital days have increased from 49.2 days to 69.8 days
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Sai Life Sciences Ltd.?
Sai Life Sciences Ltd. (SAILIFE) last closed at ₹1,800.20 (-6.67% on the day).
What is the market cap of Sai Life Sciences Ltd.?
About ₹38,240 Cr.
What is the P/E ratio of Sai Life Sciences Ltd.?
The price-to-earnings ratio is 101.6, and return on equity is 15.1%.
Figures are calculated from company results and exchange prices and are for information only.